(NYSE: TMO) Thermo Fisher Scientific's forecast annual revenue growth rate of 3.43% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 4.8%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.67%.
Thermo Fisher Scientific's revenue in 2025 is $43,212,000,000.On average, 10 Wall Street analysts forecast TMO's revenue for 2025 to be $16,576,656,671,355, with the lowest TMO revenue forecast at $16,462,398,418,171, and the highest TMO revenue forecast at $16,637,061,394,291. On average, 10 Wall Street analysts forecast TMO's revenue for 2026 to be $17,348,374,633,188, with the lowest TMO revenue forecast at $17,081,661,905,556, and the highest TMO revenue forecast at $17,702,078,620,359.
In 2027, TMO is forecast to generate $18,466,856,071,408 in revenue, with the lowest revenue forecast at $18,031,027,867,326 and the highest revenue forecast at $18,914,968,753,011.